primary biliary cholangitis
Intercept shares dive after FDA safety alert on liver drug
Richard Staines
Gilead, Intercept Pharmaceuticals, NASH, primary biliary cholangitis, Shire
0 Comment
Regulator warns of death risk in patients on higher than recommended dose.
X
Intercept shares dive after FDA safety alert on liver drug
https://pharmaphorum.com/news/intercept-shares-fda-safety/
Intercept’s liver drug gets green light from NICE
Richard Staines
Allergan, cost-effectiveness, Gilead, Intercept, NICE, primary biliary cholangitis, Shire
0 Comment
NHS patients to get access to drug in PBC.
X
Intercept’s liver drug gets green light from NICE
https://pharmaphorum.com/news/intercepts-liver-drug-nice/
EU regulator recommends Intercept’s potential liver blockbuster
Richard Staines
Intercept, liver, orphan, primary biliary cholangitis
0 Comment
Sales forecast to reach $2.6 billion in 2020.
X
EU regulator recommends Intercept’s potential liver blockbuster
https://pharmaphorum.com/news/eu-regulators-back-intercepts-potential-liver-blockbuster/